Skip to main content
SpringerLink
Log in

Effects of immunotherapeutic strategies on cerebrospinal fluid parameters in multiple sclerosis

  • Conference paper
Cerebrospinal Fluid Analysis in Multiple Sclerosis

Abstract

Therapeutic strategies in MS are generally based on treatment with anti-inflammatory, immunosuppressive or immunomodulatory agents. Most applied therapeutic agents in MS are: corticosteroids, cyclophosphamide, azathioprine, cyclosporine, interferon, total lymphoid irradiation, plasma exchange, monoclonal antibodies, copolymer-I and immunoglobulins. Modes of administration are: oral, intramuscular, intravenous or intrathecal; administration of drugs can be carried out by both a short course of high dose or a chronic low dose during an extended period.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Frequin STFM, Barkhof F, Lamers KJB, Hommes OR, Borm GF (1992) CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high-dose intravenous methylprednisolone. Acta Neurol Scand 86:291–297

    Article  PubMed  CAS  Google Scholar 

  2. Frequin STFM, Lamers KJB, Barkhof F, Brom GF, Hommes OR (1994) Follow-up study of MS patients treated with high-dose intravenous methylprednisolone. Acta Neurol Scand 90:105–110

    Article  PubMed  CAS  Google Scholar 

  3. Anderson TJ, MacG Donaldson I, Sheat M, George PM (1990) Methylprednisolone in multiple sclerosis exacerbation: changes in CSF parameters. Aus NZ J Med 20:794–797

    Article  CAS  Google Scholar 

  4. Wender M, Tokarz E, Michalowska G, Wajgt A (1986) Therapeutic trials of multiple sclerosis and intrathecal IgG production. Ital J Neurol Sci 7:205–208

    Article  PubMed  CAS  Google Scholar 

  5. Durelli L, Cocito D, Riccio A, Barile C, Bergamasco B, Baggio GF, Perla F, Delsedime M, Gusmaroli G, Berganini L (1986) High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations. Neurol 36:238–243

    CAS  Google Scholar 

  6. Warren KG, Catz I, Jeffrey VM, Carroll DJ (1986) Effect of methylprednisolone on CSF IgG parameters, myelin basic protein and anti-myelin basic protein in multiple sclerosis exacerbations. Can J Neurol Sci 13:25–30

    PubMed  CAS  Google Scholar 

  7. Caputo D, Zaffaroni M, Ghezzi A, Cazzullo CL (1987) Azathioprine reduces intrathecal IgG synthesis in multiple sclerosis. Acta Neurol Scand 75:84–86

    Article  PubMed  CAS  Google Scholar 

  8. Staugaitis SM, Shapshak P, Myers LW, Ellison GW, Tourtellotte WW, Lee M (1985) Azathioprine and steroids are not more effective in decreasing multiple sclerosis intra-blood-brain-barrier IgG synthesis than steroids alone. Ann Neurol 18:356–357

    Article  PubMed  CAS  Google Scholar 

  9. Hommes OR, Lamers KJB, Geel van WJA (1985) Intrathecal IgG synthesis and IgG index after intensive and chronic immunosuppressive treatment of multiple sclerosis. Ann N Y Acad Sci 436:410–417

    Article  Google Scholar 

  10. Wajgt A, Górny M, Szcechowski L, Grzybowski G, Ochudlo S (1989) Effect of immunosuppressive therapy on humoral immune response in multiple sclerosis. Acta Med Pol 30(3–4):121–128

    PubMed  CAS  Google Scholar 

  11. Panitch HS, Francis GS, Hooper CJ, Merigan TC, Johnson KP (1985) Serial immunological studies in multiple sclerosis patients treated systemically with human alpha interferon. Ann Neurol 18:434–438

    Article  PubMed  CAS  Google Scholar 

  12. Baumhefner RW, Tourtellotte WW, Syndulko K, Staugaitis A, Shapshak P (1989) Multiple sclerosis intra-blood-brain-barrier IgG synthesis: effect of pulse intravenous and intrathecal corticosteroids. Ital J Neurol Sci 10:19–32

    Article  PubMed  CAS  Google Scholar 

  13. Confavreux C, Chapuis-Cellier C, Arnaud P, Robert O, Aimard G, Devic M (1986) Oligoclonal “fingerprint” of CSF IgG in multiple sclerosis patients is not modified following intrathecal administration of natural beta-interferon. J Neurol Neurosurg Psych 49:1308–1312

    Article  CAS  Google Scholar 

  14. Munster van ETL (1991) Thesis, pp 53–71

    Google Scholar 

  15. Sharief MK, Thompson EJ (1991) Intrathecal immunoglobulin M synthesis in multiple sclerosis. Brain 114:181–195

    PubMed  Google Scholar 

  16. Durelli L, Poccardi G, Cavallo R (1991) CD8+ high CD11b+ low T cells (T suppressor-effectors) in multiple sclerosis cerebrospinal fluid are increased during high dose corticosteroid treatment. J Neuroimmunol 31:221–228

    Article  PubMed  CAS  Google Scholar 

  17. Huber M, Bamborschke S, Assheuer J, Heiß WD (1988) Intravenous natural beta interferon treatment of chronic exacerbating-remitting multiple sclerosis: clinical response and MRI/CSF findings. J Neurol 235:171–173

    Article  PubMed  CAS  Google Scholar 

  18. Uitdehaag BMJ, Nillesen WM, Hommes OR (1989) Long-lasting effects of cyclophosphamide on lymphocytes in peripheral blood and spinal fluid. Acta Neurol Scand 79:12–17

    Article  PubMed  CAS  Google Scholar 

  19. Salmaggi A, Milanese C, Eoli M, Mantia la L, Nespolo A, Dufour A (1994) Immunological monitoring and clinical evaluation in cyclophosphamide-treated progressive multiple sclerosis patients. Int J Neurosci 76:305–312

    Article  PubMed  CAS  Google Scholar 

  20. Dufour A, Salmaggi A, Mantia la L, Eoli M, Nespolo A, Milanese C (1994) High-dose methylprednisolone treatment-induced changes in immunological parameters in progressive MS patients. Int J Neurosci 75:119–128

    Article  PubMed  CAS  Google Scholar 

  21. Frequin STFM, Lamers KJB, Barkhof F, Jongen PJH, Hommer OR (1993) T-cell subsets in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients treated with high-dose intravenous methylprednisolone. Acta Neurol Scand 88:80–86

    Article  PubMed  CAS  Google Scholar 

  22. Brinkman CJJ, Nillesen WM, Hommes OR (1984) The effect of cyclophosphamide on T lymphocytes and T lymphocyte subsets in patients with chronic progressive multiple sclerosis. Acta Neurol Scand 69:90–96

    Article  PubMed  CAS  Google Scholar 

  23. Polman CH, Groot de CJA, Koetsier JC, Sminia T, Veerman AJP (1987) Cerebrospinal fluid cells in multiple sclerosis and other neurological diseases: an immunocytochemical study. J Neurol 234:19–22

    Article  PubMed  CAS  Google Scholar 

  24. Barkhof F, Frequin STFM, Hommes OR, Lamers KJB, Scheltens P, Geel van WJA, Valk J (1992) A correlative triad of gadolinium-DTPA MRI, EDSS, and CSF-MBP in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone. Neurol 42:63–67

    CAS  Google Scholar 

  25. Lamers KJB, Uitdehaag BMJ, Hommes OR, Doesburg W, Wevers RA, Geel van WJA (1988) The short-term effect of an immunosuppressive treatment on CSF myelin basic protein in chronic progressive multiple sclerosis. J Neurol Neurosurg Psych 51:1334–1337

    Article  CAS  Google Scholar 

  26. Whitaker JN, Layton BA, Herman PK, Kachelhofer RD, Burgard S, Bartolucci AA (1993) Correlation of myelin basic protein-like material in cerebrospinal fluid of multiple sclerosis patients with their response to glucocorticoid treatment. Ann Neurol 33:10–17

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Neurology, University Hospital Nijmegen, PO Box 9101, 6500 HB, Nijmegen, The Netherlands

    K. J. B. Lamers & O. R. Hommes

  2. St. Antonius Hospital, Institute of Neurology, PO Box 2500, 3430 EM, Nieuwegein, The Netherlands

    S. T. F. M. Frequin

Authors
  1. K. J. B. Lamers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. T. F. M. Frequin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. O. R. Hommes
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Italia, Milano

About this paper

Cite this paper

Lamers, K.J.B., Frequin, S.T.F.M., Hommes, O.R. (1996). Effects of immunotherapeutic strategies on cerebrospinal fluid parameters in multiple sclerosis. In: Cerebrospinal Fluid Analysis in Multiple Sclerosis. Springer, Milano. https://doi.org/10.1007/978-88-470-2205-8_10

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2205-8_10

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2207-2

  • Online ISBN: 978-88-470-2205-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation